Pre-market
You're reading the free version. Trader adds the live tape and alerts. Start tracking

Price with disclosed trades

Daily closes, past year · marks sit on transaction dates, sized by value

4 trades

Disclosure transactions for Relmada Therapeutics
Reporting person Filed Transaction Transaction value Source Actions
Shenouda Maged Chief Financial Officer Sep 11, 2026 1-day lag Buy Sep 10, 2026 $339.15K Filed shares x price SEC Form 4 View filing
Shenouda Maged Chief Financial Officer Sep 11, 2026 2-day lag Buy Sep 9, 2026 $504.84K Filed shares x price SEC Form 4 View filing
Traversa Sergio Chief Executive Officer Sep 11, 2026 1-day lag Buy Sep 10, 2026 $410K Filed shares x price SEC Form 4 View filing
Traversa Sergio Chief Executive Officer Sep 11, 2026 2-day lag Buy Sep 9, 2026 $418K Filed shares x price SEC Form 4 View filing
Shenouda Maged Chief Financial Officer
Buy
Calculated transaction value
$339.15K 79,800 shares @ $4.25
Traded
Sep 10, 2026
Filed
Sep 11, 2026
Shenouda Maged Chief Financial Officer
Buy
Calculated transaction value
$504.84K 120,200 shares @ $4.2
Traded
Sep 9, 2026
Filed
Sep 11, 2026
Traversa Sergio Chief Executive Officer
Buy
Calculated transaction value
$410K 100,000 shares @ $4.1
Traded
Sep 10, 2026
Filed
Sep 11, 2026
Traversa Sergio Chief Executive Officer
Buy
Calculated transaction value
$418K 100,000 shares @ $4.18
Traded
Sep 9, 2026
Filed
Sep 11, 2026